Ironwood Pharmaceuticals recently launched a drug called Linzess, and the company also reported an EPS loss; and Mad Money host Jim Cramer answers viewers' investment questions.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT